Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 79
  2. 80
  3. 81
  4. 82
  5. 83
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Cemiplimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5161-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Cemiplimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5161-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Cemiplimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5161-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Cemiplimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5161-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Cemiplimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5161-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Glembatumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5163-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Glembatumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5163-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Glembatumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5163-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Glembatumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5163-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Glembatumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5163-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Glembatumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5163-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Naxitamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5164-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Naxitamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5164-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Naxitamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5164-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Naxitamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5164-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Naxitamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5164-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Naxitamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5164-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Ixekizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5165-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Ixekizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5165-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Ixekizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5165-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Ixekizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5165-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Ixekizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5165-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Ixekizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5165-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Lenzilumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5166-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Lenzilumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5166-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Name Preis
Cemiplimab Biosimilar -­ Research Grade Anmelden Cemiplimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Cemiplimab Biosimilar -­ Research Grade Anmelden Cemiplimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Cemiplimab Biosimilar -­ Research Grade Anmelden Cemiplimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Cemiplimab Biosimilar -­ Research Grade Anmelden Cemiplimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Cemiplimab Biosimilar -­ Research Grade Anmelden Cemiplimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Glembatumumab Biosimilar -­ Research Grade Anmelden Glembatumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Glembatumumab Biosimilar -­ Research Grade Anmelden Glembatumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Glembatumumab Biosimilar -­ Research Grade Anmelden Glembatumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Glembatumumab Biosimilar -­ Research Grade Anmelden Glembatumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Glembatumumab Biosimilar -­ Research Grade Anmelden Glembatumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Glembatumumab Biosimilar -­ Research Grade Anmelden Glembatumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Naxitamab Biosimilar -­ Research Grade Anmelden Naxitamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Naxitamab Biosimilar -­ Research Grade Anmelden Naxitamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Naxitamab Biosimilar -­ Research Grade Anmelden Naxitamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Naxitamab Biosimilar -­ Research Grade Anmelden Naxitamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Naxitamab Biosimilar -­ Research Grade Anmelden Naxitamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Naxitamab Biosimilar -­ Research Grade Anmelden Naxitamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Ixekizumab Biosimilar -­ Research Grade Anmelden Ixekizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Ixekizumab Biosimilar -­ Research Grade Anmelden Ixekizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Ixekizumab Biosimilar -­ Research Grade Anmelden Ixekizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Ixekizumab Biosimilar -­ Research Grade Anmelden Ixekizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Ixekizumab Biosimilar -­ Research Grade Anmelden Ixekizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Ixekizumab Biosimilar -­ Research Grade Anmelden Ixekizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Lenzilumab Biosimilar -­ Research Grade Anmelden Lenzilumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Lenzilumab Biosimilar -­ Research Grade Anmelden Lenzilumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 79
  2. 80
  3. 81
  4. 82
  5. 83
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top